LU69479A1 - - Google Patents

Info

Publication number
LU69479A1
LU69479A1 LU69479A LU69479A LU69479A1 LU 69479 A1 LU69479 A1 LU 69479A1 LU 69479 A LU69479 A LU 69479A LU 69479 A LU69479 A LU 69479A LU 69479 A1 LU69479 A1 LU 69479A1
Authority
LU
Luxembourg
Application number
LU69479A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU69479A1 publication Critical patent/LU69479A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU69479A 1973-02-26 1974-02-22 LU69479A1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB924973A GB1433774A (en) 1973-02-26 1973-02-26 Heterocyclic compounds apparatus for conveying articles

Publications (1)

Publication Number Publication Date
LU69479A1 true LU69479A1 (enExample) 1975-05-21

Family

ID=9868317

Family Applications (1)

Application Number Title Priority Date Filing Date
LU69479A LU69479A1 (enExample) 1973-02-26 1974-02-22

Country Status (14)

Country Link
JP (1) JPS5029574A (enExample)
AT (1) AT329562B (enExample)
AU (1) AU474797B2 (enExample)
BE (1) BE811246A (enExample)
CA (1) CA1025856A (enExample)
CH (1) CH602707A5 (enExample)
DE (1) DE2407744A1 (enExample)
FR (1) FR2218896B1 (enExample)
GB (1) GB1433774A (enExample)
IE (1) IE38886B1 (enExample)
LU (1) LU69479A1 (enExample)
NL (1) NL7402613A (enExample)
SE (1) SE7401984L (enExample)
ZA (1) ZA74883B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2324304A2 (fr) * 1975-09-22 1977-04-15 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
US4186201A (en) 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4264604A (en) 1977-07-01 1981-04-28 Ciba-Geigy Corporation Quinolonecarboxylic acid derivatives as bactericides
US4390541A (en) 1980-12-19 1983-06-28 Lilly Industries Limited Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4377579A (en) 1981-12-03 1983-03-22 Minnesota Mining And Manufacturing Company N-(Tetrazol-5-yl)phenazine-1-carboxamides
FR2537140B1 (fr) * 1982-12-07 1986-07-18 Roussel Uclaf Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
ATE82282T1 (de) * 1987-01-20 1992-11-15 Dainippon Pharmaceutical Co Aromatische heterozyklische karbonsaeureamidabkoemmlinge, verfahren zur herstellung und arzneimittel, die diese enthalten.
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
JP2001514181A (ja) * 1997-08-25 2001-09-11 ニューロゲン コーポレイション Gaba脳レセプタリガンドとしての置換4−オキソ−ナフチリジン−3−カルボキサミド
US6143760A (en) * 1997-08-25 2000-11-07 Neurogen Corporation Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
DE69925462T2 (de) * 1998-02-26 2006-02-02 Neurogen Corp., Branford Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande
KR20040107525A (ko) * 2002-05-14 2004-12-20 더 리전트 오브 더 유니버시티 오브 캘리포니아 치환된 퀴놀론 카르복실산, 이들의 유도체, 그의 작용부위 및 용도
WO2005009971A1 (ja) 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
RU2556984C2 (ru) * 2004-06-24 2015-07-20 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы транспортеров атф-связывающей кассеты
EP3216787B1 (en) * 2004-06-24 2020-02-19 Vertex Pharmaceuticals Incorporated Intermediates for the preparation of modulators of atp-binding cassette transporters
PL2502911T3 (pl) * 2004-06-24 2017-09-29 Vertex Pharma Modulatory transporterów kasety wiążącej ATP
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
CA3071058C (en) 2009-03-20 2023-01-24 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
MX389751B (es) 2012-02-27 2025-03-20 Vertex Pharma Composición farmacéutica y administraciones de la misma.
WO2013129622A1 (ja) 2012-03-02 2013-09-06 武田薬品工業株式会社 複素環化合物およびその用途
WO2014077401A1 (ja) 2012-11-19 2014-05-22 武田薬品工業株式会社 含窒素複素環化合物
RU2749213C2 (ru) 2014-10-07 2021-06-07 Вертекс Фармасьютикалз Инкорпорейтед Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе
CN105330602B (zh) * 2015-12-07 2018-02-09 江南大学 一种癸氧喹酯类似物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383088A (en) * 1972-07-03 1975-02-05 Allen & Hanburys Ltd Pharmacologically active quinaldamide derivatives

Also Published As

Publication number Publication date
CH602707A5 (enExample) 1978-07-31
IE38886B1 (en) 1978-06-21
GB1433774A (en) 1976-04-28
ATA149974A (de) 1975-08-15
AT329562B (de) 1976-05-25
CA1025856A (en) 1978-02-07
BE811246A (fr) 1974-08-19
FR2218896B1 (enExample) 1977-09-09
FR2218896A1 (enExample) 1974-09-20
AU6559274A (en) 1975-08-14
IE38886L (en) 1974-08-26
SE7401984L (enExample) 1974-08-27
AU474797B2 (en) 1976-08-05
JPS5029574A (enExample) 1975-03-25
DE2407744A1 (de) 1974-08-29
NL7402613A (enExample) 1974-08-28
ZA74883B (en) 1974-12-24

Similar Documents

Publication Publication Date Title
AU476761B2 (enExample)
AU474593B2 (enExample)
AU474511B2 (enExample)
FR2218896B1 (enExample)
AU474838B2 (enExample)
AU472848B2 (enExample)
AU476696B2 (enExample)
AU477823B2 (enExample)
AU471461B2 (enExample)
AU477824B2 (enExample)
AR210729A1 (enExample)
AU476873B1 (enExample)
BG20675A1 (enExample)
AU479521A (enExample)
CH564716A5 (enExample)
CH564396A5 (enExample)
CH562702A5 (enExample)
CH562637A5 (enExample)
CH560499A5 (enExample)
CH377075A4 (enExample)
BG21367A3 (enExample)
BG20202A1 (enExample)
BG20047A1 (enExample)
AU481017A (enExample)
AU479562A (enExample)